{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:22:35Z","timestamp":1794878555203,"version":"4.9.1"},"reference-count":10,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1111\/j.1365-2125.2008.03174.x","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T19:06:52Z","timestamp":1207076812000},"page":"325-326","source":"Crossref","is-referenced-by-count":11,"title":["Nail and periungual toxicity following capecitabine therapy"],"prefix":"10.1111","volume":"66","author":[{"given":"Mario","family":"Vaccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Barbuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,14]]},"reference":[{"key":"e_1_2_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2007.01.006"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.01.005"},{"key":"e_1_2_2_5_2","first-page":"1653","article-title":"Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side\u2010effects","volume":"27","author":"Stathopoulos GP","year":"2007","journal-title":"Anticancer Res"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdg050"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.09.013"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2001.04391.x"},{"key":"e_1_2_2_9_2","first-page":"234","article-title":"Onycholysis with the appearance of a \u2018sunset\u2019 secondary to capecitabine","volume":"72","author":"Maino KL","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.05000_6.x"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05272.x"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2008.03174.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2008.03174.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:07:39Z","timestamp":1697429259000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2008.03174.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,14]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1365-2125.2008.03174.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03174.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,14]]}}}